Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence — Stella

Home/Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Outpatient CTRC, Aurora, Colorado

University of Colorado Cancer Center, Aurora, Colorado

Key details

Phase

Early testing

Sponsor

University of Colorado, Denver

Collaborators

Usona Institute

Enrollment target

~20 participants

Started

November 2024

Primary completion

December 2026

Age range

21 Years and older

Sex

Female only

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.